Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation

Annals of Internal Medicine

Volumn 160, Issue 6, 2014, Pages

  Giugliano, R P ^a   Johnson, Stacy A ^b   Rondina, Matthew T ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRONEDARONE; EDOXABAN; PLACEBO; QUINIDINE; VERAPAMIL; WARFARIN;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRUG DOSE REDUCTION; DRUG SAFETY; EMBOLISM; EMBOLISM PREVENTION; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMIC DISEASE; SYSTEMIC EMBOLISM;

BARIATRIC SURGERY; HUMANS; OBESITY;

EID: 84896531122     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-160-6-201403180-02007     Document Type: Note

References (2)

1. Granger CB, Alexander JH, McMurray JJ, et al; ARISOTLE Committees and Investigators. N Engl J Med. 2011;365:981-92.
2. Mahaffey KW, Hellkamp AS, Patel MR, et al. Circ Cardiovasc Qual Outcomes. 2013;6:470-8.